Table 3.
Adverse reactions to DAAs in the study groups
| Patients with cryoglobulinemia (N = 56) |
Patients with SLE (N = 5) | Patients with CKD (hypertensive or diabetic) (N = 111) | Patients undergoing hemodialysis (N = 48) | Patients after kidney transplantation (N = 12) | |
|---|---|---|---|---|---|
| Asthenia/ Fatigue | 10 pts. (17.8%) | 2pts (40%) | 50 pts. (45%) | 7 pts. (14.5%) | 2 pts. (16.6%) |
| Nausea | 8 pts. (14.2%) | 0 pts | 22 pts. (20%) | 12 pts. (25%) | 3 pts. (25%) |
| Headache | 17pts (30.3%) | 2 pts. (20%) | 36 pts. (33%) | 8 pts. (16,6%) | 0 pts |
| Diarrhea | 2 pts. (3.5%) | 0 pts | 7 pts. (6.3%) | 3 pts. (6.2%) | 1 pts. (8.3%) |
| Dizziness | 12 pts. (21.4%) | 1 pts. (20%) | 41 pts. (36.9%) | 10 pts. (20.8%) | 1 pts. (8.3%) |